{"entity":{"type":"insider","cik":"0001953625","url":"/insider/0001953625","json_url":"/insider/0001953625.json","name":"Aequanimitas Limited Partnership","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2022-11-07","last":"2023-12-08","span_basis":"filed_date"},"name_variants":[{"name":"Aequanimitas Limited Partnership","source":"filing","n_filings":4,"first_seen":"2022-11-07","last_seen":"2023-12-08"}],"transactions":[{"id":8146554,"accession":"0001104659-23-124723","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-124723","line_url":"/filing/0001104659-23-124723#line-1","is_derivative":false,"issuer_cik":"0001854578","issuer_name":"Rani Therapeutics Holdings, Inc.","issuer_ticker":"RANI","issuer_name_source":null,"issuer_url":"/issuer/0001854578","owner_cik":null,"owner_name":"Quiroga Cortes Isidoro Alfonso; Aequanimitas Limited Partnership","owner_display_name":"Quiroga Cortes Isidoro Alfonso","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5265165.0,"shares_display":"5,265,165","price_per_share":2.01,"price_display":"2.01","price_state":"stated","total_value":10582981.65,"total_display":"10,582,981.65","total_whole":"10,582,982","shares_owned_after":8400.0,"shares_owned_after_display":"8,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-24","filed_date":"2023-12-08","scope":"insider"},{"id":7890926,"accession":"0001104659-23-000497","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-000497","line_url":"/filing/0001104659-23-000497#line-1","is_derivative":false,"issuer_cik":"0001854578","issuer_name":"Rani Therapeutics Holdings, Inc.","issuer_ticker":"RANI","issuer_name_source":null,"issuer_url":"/issuer/0001854578","owner_cik":null,"owner_name":"Quiroga Cortes Isidoro Alfonso; Aequanimitas Limited Partnership","owner_display_name":"Quiroga Cortes Isidoro Alfonso","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8400.0,"shares_display":"8,400","price_per_share":6.0258,"price_display":"6.03","price_state":"stated","total_value":50616.72,"total_display":"50,616.72","total_whole":"50,617","shares_owned_after":5271378.0,"shares_owned_after_display":"5,271,378","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-30","filed_date":"2023-01-03","scope":"insider"},{"id":6991048,"accession":"0001104659-22-115484","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-115484","line_url":"/filing/0001104659-22-115484#line-1","is_derivative":false,"issuer_cik":"0001854578","issuer_name":"Rani Therapeutics Holdings, Inc.","issuer_ticker":"RANI","issuer_name_source":null,"issuer_url":"/issuer/0001854578","owner_cik":null,"owner_name":"Quiroga Cortes Isidoro Alfonso; Aequanimitas Limited Partnership","owner_display_name":"Quiroga Cortes Isidoro Alfonso","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15192.0,"shares_display":"15,192","price_per_share":6.898,"price_display":"6.90","price_state":"stated","total_value":104794.416,"total_display":"104,794.42","total_whole":"104,794","shares_owned_after":5262978.0,"shares_owned_after_display":"5,262,978","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-03","filed_date":"2022-11-07","scope":"insider"},{"id":9223758,"accession":"0001104659-22-115487","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-115487","line_url":"/filing/0001104659-22-115487#line-3","is_derivative":false,"issuer_cik":"0001854578","issuer_name":"Rani Therapeutics Holdings, Inc.","issuer_ticker":"RANI","issuer_name_source":null,"issuer_url":"/issuer/0001854578","owner_cik":null,"owner_name":"Aequanimitas Limited Partnership; Quiroga Cortes Isidoro Alfonso","owner_display_name":"Aequanimitas Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25197.0,"shares_display":"25,197","price_per_share":6.3085,"price_display":"6.31","price_state":"stated","total_value":158955.2745,"total_display":"158,955.27","total_whole":"158,955","shares_owned_after":5247786.0,"shares_owned_after_display":"5,247,786","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-07","scope":"insider"},{"id":9223759,"accession":"0001104659-22-115487","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-115487","line_url":"/filing/0001104659-22-115487#line-2","is_derivative":false,"issuer_cik":"0001854578","issuer_name":"Rani Therapeutics Holdings, Inc.","issuer_ticker":"RANI","issuer_name_source":null,"issuer_url":"/issuer/0001854578","owner_cik":null,"owner_name":"Aequanimitas Limited Partnership; Quiroga Cortes Isidoro Alfonso","owner_display_name":"Aequanimitas Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3768.0,"shares_display":"3,768","price_per_share":5.9802,"price_display":"5.98","price_state":"stated","total_value":22533.3936,"total_display":"22,533.39","total_whole":"22,533","shares_owned_after":5222589.0,"shares_owned_after_display":"5,222,589","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-07","scope":"insider"},{"id":9223760,"accession":"0001104659-22-115487","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-115487","line_url":"/filing/0001104659-22-115487#line-1","is_derivative":false,"issuer_cik":"0001854578","issuer_name":"Rani Therapeutics Holdings, Inc.","issuer_ticker":"RANI","issuer_name_source":null,"issuer_url":"/issuer/0001854578","owner_cik":null,"owner_name":"Aequanimitas Limited Partnership; Quiroga Cortes Isidoro Alfonso","owner_display_name":"Aequanimitas Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16523.0,"shares_display":"16,523","price_per_share":6.1113,"price_display":"6.11","price_state":"stated","total_value":100977.0099,"total_display":"100,977.01","total_whole":"100,977","shares_owned_after":5218821.0,"shares_owned_after_display":"5,218,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001856725","name":"Rani Therapeutics Holdings, Inc.","url":"/issuer/0001856725","role":"Ten percent owner","n_filings":4,"first_seen":"2022-11-07","last_seen":"2023-12-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001953625","retrieved_at":"2026-08-27T14:04:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}